Osilodrostat and Triptorelin: Interaction Details

Brand names
Osilodrostat
Isturisa
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
Share

Share this interaction

Triptorelin

We don't have a drug information page for Triptorelin yet. Have a question about Triptorelin? Ask a pharmacist, free →

What Happens When You Take Osilodrostat With Triptorelin

What can happen when they are taken together (rated Major)

Increased risk of

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

Osilodrostat should be combined with other QT-prolonging drugs only with caution, because it is associated with dose-dependent prolongation of the . When such combinations are used, more frequent monitoring may be warranted. If the exceeds 480 milliseconds, temporarily discontinuing osilodrostat should be considered.1

The Osilodrostat and Triptorelin Interaction, Explained

Both osilodrostat (Isturisa, used for Cushing's syndrome) and triptorelin (a hormone-lowering medicine, often used for prostate cancer or other hormone-related conditions) can affect the heart's electrical rhythm. This is called . Taking them together could add up that effect and may raise the chance of an irregular heartbeat, though this is based on theory rather than proven cases.

Many people never notice anything. Rarely, signs can include fainting, dizziness, or a racing or fluttering heartbeat. Keep taking both medicines as prescribed. Your care team may check your heart rhythm with an more often and can tailor your treatment if needed. Tell them about any other medicines you take.

Mechanism: (). Osilodrostat causes dose-dependent QTc prolongation; triptorelin (GnRH ) is associated with QT prolongation, particularly via androgen deprivation. No relevant activation or -mediated exposure change is the basis here.

  • Direction: increased risk of QTc prolongation and (e.g., ).
  • Evidence: theoretical; onset unspecified.
  • Management: use caution; consider more frequent monitoring; consider temporary osilodrostat interruption if exceeds 480 ms. Correct electrolytes (K, Mg) and review other QT-prolonging drugs.

See the 1 reference behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Osilodrostat and Triptorelin Interact

The likely mechanism


In short: Osilodrostat and triptorelin both lengthen the QT interval, a measure of the heart’s rhythm, so taken together the effect can add up.
How Drug Interactions Work See this kind of interaction drawn out, step by step, in “When Effects Add Up or Cancel Out”, one chapter of our one-minute explainer. See how it works 

How to Manage the Osilodrostat and Triptorelin Interaction

Your care team can manage this combination with closer monitoring and individualized dosing.

  • What your team may do: check your heart rhythm with ECGs more often. If your (a measure on the ) rises above 480 milliseconds, they may consider pausing osilodrostat temporarily.
  • What you can do: keep taking both medicines as prescribed and do not change or stop either on your own.
  • Tell your pharmacist or prescriber about any other medicines or supplements you take.
  • Report fainting, severe dizziness, or a fast or irregular heartbeat promptly.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Osilodrostat or Triptorelin need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Osilodrostat and Triptorelin: Common Questions

How serious is the Osilodrostat and Triptorelin interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How is the Osilodrostat and Triptorelin interaction managed?

Your care team can manage this combination with closer monitoring and individualized dosing. What your team may do: check your heart rhythm with ECGs more often. If your (a measure on the ) rises above 480 milliseconds, they may consider pausing osilodrostat temporarily. What you can do: keep taking both medicines as prescribed and do not change or stop either on your own. Tell your pharmac… Management is individual — always follow your own care team's guidance.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

Ask About the Osilodrostat and Triptorelin Interaction

Ask in your own words about taking Osilodrostat and Triptorelin together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (1)

  1. Product Information: ISTURISA(R) oral tablets, osilodrostat oral tablets. Recordati Rare Disease Inc (per FDA), Lebanon, NJ, 2020. DailyMed
Was this write-up helpful?

Other Serious Interactions of Osilodrostat and Triptorelin

Also serious with Osilodrostat

Also serious with Triptorelin

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together.
  • Major Potentially serious — often needs a change or close monitoring. This interaction.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized. This interaction.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.